Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis
Am J Physiol Lung Cell Mol Physiol Poschet et al.
293: L712
Supplemental Figures
2 figures, plus supplemental methods, notes, and references. PDF format